Jan 15, 2021 1:30pm EST Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th
Dec 16, 2020 8:30am EST Emerald Bioscience Reports that Superior Reduction of Intraocular Pressure of its Unique Nanoemulsion Formulation of THCVHS is Published in Peer-Reviewed Journal
Dec 07, 2020 8:44am EST Emerald Bioscience to Present at the Benzinga Global Small Cap Virtual Conference
Sep 03, 2020 11:39am EDT Emerald Bioscience to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Aug 13, 2020 8:30am EDT Emerald Bioscience Appoints Biotech Veteran Dr. Margaret Dalesandro to Board of Directors
Aug 04, 2020 6:32pm EDT Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering
